Cerebrospinal fluid (CSF) is a clear, colorless body fluid found in the brain and spine which acts as a cushion or buffer for the brain’s cortex, providing basic mechanical and immunological protection to the brain inside the skull. The CSF also serves a vital function in cerebral autoregulation of cerebral blood flow. Cerebrospinal fluid management products are primarily used for the treatment of hydrocephalus due to excessive accumulation of cerebrospinal fluid that can lead to rise in intracranial pressure. Growing demand and awareness about the benefits of cerebrospinal fluid management products supports the high growth of the cerebrospinal fluid management market.
The global cerebrospinal fluid management market report provides market size estimates (Revenue USD million – 2014 to 2021) for key market segments based on CSF product type (CSF shunts), CSF drainage systems (ventricular drainage system, lumbar drainage system), and also forecasts growth trends (CAGR% – 2017 to 2021).
The global cerebrospinal fluid management market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cerebrospinal fluid management market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global cerebrospinal fluid management market and included in this report are DePuy Synthes (a J & J Company), Medtronic plc, B. Braun Melsungen AG, Sophysa S.A., Spiegelberg GmbH & Co. KG, Integra LifeSciences Holdings Corporation, BeckerSmith Medical, Inc., and Möller Medical GmbH.